CEMI : Summary for Chembio Diagnostics, Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 32 mins

Chembio Diagnostics, Inc. (CEMI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.40-0.10 (-1.82%)
As of 11:21AM EDT. Market open.
People also watch
CASMCCXIAHPICPIXBLFS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close5.50
Open5.35
Bid5.40 x 200
Ask5.45 x 1400
Day's Range5.35 - 5.45
52 Week Range5.05 - 9.40
Volume4,340
Avg. Volume24,091
Market Cap66.42M
Beta1.55
PE Ratio (TTM)-4.29
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube10 days ago

    Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Chembio Diagnostics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Chembio Diagnostics, Inc. – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A, Trinity Biotech Plc Sponsored ADR Class A and OraSure Technologies, Inc. (QDEL-US, BIO-US, TRIB-US and OSUR-US) that ... Read more (Read more...)

  • Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube12 days ago

    Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Chembio Diagnostics, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Chembio Diagnostics, Inc. – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A and OraSure Technologies, Inc. (QDEL-US, BIO-US and OSUR-US) that have also reported for this period. Highlights Gross ... Read more (Read more...)

  • Zacks Small Cap Research17 days ago

    CEMI: Surprise Rebound In Lateral Flow, Expect DPP Strong Showing In 2017

    Chembio (CEMI) reported financial results for the fourth quarter ending December 31st.  Both revenue and EPS came in very much inline with our estimates, although within the itemized revenue there were some differences – most notably lateral flow coming in much stronger than we had anticipated but which was offset by weaker than expected DPP sales.